Effects of interferon-γ on secretion of vascular endothelial growth factor by endometrial stromal cells

被引:32
作者
Kawano, Y [1 ]
Matsui, N [1 ]
Kamihigashi, S [1 ]
Narahara, H [1 ]
Miyakawa, I [1 ]
机构
[1] Oita Med Univ, Dept Obstet & Gynecol, Oita 8795593, Japan
来源
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY | 2000年 / 43卷 / 01期
关键词
endometrial stromal cells; interferon-gamma; vascular endothelial growth factor;
D O I
10.1111/j.8755-8920.2000.430109.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
PROBLEM: The aim of this study was to clarify the physiological effects of interferon (IFN)-gamma on secretion of vascular endothelial growth factor (VEGF) by endometrial stromal (ES) cells. METHOD OF STUDY: ES cells were obtained from human uterine endometrium by enzymic digestion and filtration. The effects of IFN-gamma on production of VEGF by ES cells were examined by analyzing VEGF mRNA expression with Northern blotting analysis and by assaying VEGF protein. RESULTS: IFN-gamma inhibited VEGF mRNA and protein expression by ES cells in a dose-dependent manner. In ES cells treated with IFN-gamma, VEGF production was not significant until 6 hr of incubation and was significantly affected after 6 hr of incubation, but decreased significantly after 12 to 48 hr. IFN-gamma also suppressed VEGF mRNA expression by ES cells. CONCLUSIONS: ES cells produce VEGF, which may contribute to endometrial neovascularization and proliferation. IFN-gamma may play an important role in regulating VEGF production by ES cells.
引用
收藏
页码:47 / 52
页数:6
相关论文
共 28 条
[1]   INDIRECT ANGIOGENIC CYTOKINES UP-REGULATE VEGF AND BFGF GENE-EXPRESSION IN VASCULAR SMOOTH-MUSCLE CELLS, WHEREAS HYPOXIA UP-REGULATES VEGF EXPRESSION ONLY [J].
BROGI, E ;
WU, TG ;
NAMIKI, A ;
ISNER, JM .
CIRCULATION, 1994, 90 (02) :649-652
[2]   IMMUNOHISTOCHEMICAL LOCALIZATION OF INTERFERONS IN HUMAN PLACENTAL TISSUES IN NORMAL, ECTOPIC, AND MOLAR PREGNANCY [J].
BULMER, JN ;
MORRISON, L ;
JOHNSON, PM ;
MEAGER, A .
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1990, 22 (3-4) :109-116
[3]   Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele [J].
Carmeliet, P ;
Ferreira, V ;
Breier, G ;
Pollefeyt, S ;
Kieckens, L ;
Gertsenstein, M ;
Fahrig, M ;
Vandenhoeck, A ;
Harpal, K ;
Eberhardt, C ;
Declercq, C ;
Pawling, J ;
Moons, L ;
Collen, D ;
Risau, W ;
Nagy, A .
NATURE, 1996, 380 (6573) :435-439
[4]   IDENTIFICATION AND LOCALIZATION OF ALTERNATELY SPLICED MESSENGER-RNAS FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR IN HUMAN UTERUS AND ESTROGEN REGULATION IN ENDOMETRIAL CARCINOMA CELL-LINES [J].
CHARNOCKJONES, DS ;
SHARKEY, AM ;
RAJPUTWILLIAMS, J ;
BURCH, D ;
SCHOFIELD, JP ;
FOUNTAIN, SA ;
BOOCOCK, CA ;
SMITH, SK .
BIOLOGY OF REPRODUCTION, 1993, 48 (05) :1120-1128
[5]   VASCULAR ENDOTHELIAL GROWTH-FACTOR VASCULAR-PERMEABILITY FACTOR EXPRESSION IN THE RAT UTERUS - RAPID STIMULATION BY ESTROGEN CORRELATES WITH ESTROGEN-INDUCED INCREASES IN UTERINE CAPILLARY-PERMEABILITY AND GROWTH [J].
CULLINANBOVE, K ;
KOOS, RD .
ENDOCRINOLOGY, 1993, 133 (02) :829-837
[6]   THE FMS-LIKE TYROSINE KINASE, A RECEPTOR FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR [J].
DEVRIES, C ;
ESCOBEDO, JA ;
UENO, H ;
HOUCK, K ;
FERRARA, N ;
WILLIAMS, LT .
SCIENCE, 1992, 255 (5047) :989-991
[7]   ROLE OF THE FLT-1 RECEPTOR TYROSINE KINASE IN REGULATING THE ASSEMBLY OF VASCULAR ENDOTHELIUM [J].
FONG, GH ;
ROSSANT, J ;
GERTSENSTEIN, M ;
BREITMAN, ML .
NATURE, 1995, 376 (6535) :66-70
[8]   EPIDERMAL GROWTH-FACTOR STIMULATES VASCULAR ENDOTHELIAL GROWTH-FACTOR PRODUCTION BY HUMAN-MALIGNANT GLIOMA-CELLS - A MODEL OF GLIOBLASTOMA-MULTIFORME PATHOPHYSIOLOGY [J].
GOLDMAN, CK ;
KIM, J ;
WONG, WL ;
KING, V ;
BROCK, T ;
GILLESPIE, GY .
MOLECULAR BIOLOGY OF THE CELL, 1993, 4 (01) :121-133
[9]  
GRASSO G, 1983, P SOC EXP BIOL MED, V173, P276
[10]   THE RELATED FLT4, FLT1, AND KDR RECEPTOR TYROSINE KINASES SHOW DISTINCT EXPRESSION PATTERNS IN HUMAN FETAL ENDOTHELIAL-CELLS [J].
KAIPAINEN, A ;
KORHONEN, J ;
PAJUSOLA, K ;
APRELIKOVA, O ;
PERSICO, MG ;
TERMAN, BI ;
ALITALO, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2077-2088